Allan Jonathan's Form 4 filing
Stoke Therapeutics, Inc. (STOK) · filed Dec 5, 2025
- Accession no.
- 0001966716-25-000008
- Filed
- Dec 5, 2025
- Trade date
- Dec 3-5, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 1 derivative transaction. Open-market sales total $306.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Allan JonathanCIK 0001966716 | Officer (GENERAL COUNSEL & CORP SEC) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 3, 2025 | Common Stock | MOption exerciseAcquired | +6,000 | $0.00 | $0 | 25,612 | Direct | |
| Dec 4, 2025 | Common Stock | SSaleDisposed | −824 | $30.76 | −$25,346.24 | 24,788 | Direct | |
| Dec 4, 2025 | Common Stock | SSaleDisposed | −194 | $31.32 | −$6,076.08 | 24,594 | Direct | |
| Dec 5, 2025 | Common Stock | SSaleDisposed | −1,004 | $31.33 | −$31,455.32 | 23,590 | Direct | |
| Dec 5, 2025 | Common Stock | SSaleDisposed | −5,437 | $31.08 | −$168,981.96 | 18,153 | Direct | |
| Dec 5, 2025 | Common Stock | SSaleDisposed | −2,344 | $31.76 | −$74,445.44 | 15,809 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 3, 2025 | Common Stock | MOption exerciseDisposed | −6,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.